You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Topoisomerase I antibody (ab28432)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Topoisomerase I antibody
See all Topoisomerase I products (7) ...

Description

Rabbit polyclonal to Topoisomerase I

Specificity

Ab28432 recognises Topoisomerase I.

Tested applications

WB, ICC/IF, ELISAmore details

Cross reactivity

Reacts with

Human

Immunogen

Recombinant full length Topoisomerase I protein (Human).

Positive control

HeLa nuclear extract.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

Preservative: None
Constituents: PBS

Concentration

Concentration information loading...

Purity

Protein A purified

Purification notes

Ab28432 is affinity purified.

Clonality

Polyclonal

Isotype

IgG

  • Immunocytochemistry/ Immunofluorescence-Topoisomerase I antibody(ab28432)Immunocytochemistry/ Immunofluorescence-Topoisomerase I antibody(ab28432) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence - Topoisomerase I antibody (ab28432)Immunocytochemistry/ Immunofluorescence - Topoisomerase I antibody (ab28432) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab28432 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ELISA: 1/500 (PMID 19584232).
ICC/IF: Use at a concentration of 1 µg/ml.
WB: 1/2000 - 1/5000. Predicted molecular weight: 91 kDa.


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

The reaction catalyzed by topoisomerases leads to the conversion of one topological isomer of DNA to another.

Involvement in disease

Note=A chromosomal aberration involving TOP1 is found in a form of therapy-related myelodysplastic syndrome. Translocation t(11;20)(p15;q11) with NUP98.

Sequence similarities

Belongs to the eukaryotic type I topoisomerase family.

Post-translational
modifications

Sumoylated. Lys-117 is the main site of sumoylation. Sumoylation plays a role in partitioning TOP1 between nucleoli and nucleoplasm. Levels are dramatically increased on camptothecin (CPT) treatment.

Cellular localization

Nucleus > nucleolus. Nucleus > nucleoplasm. Diffuse nuclear localization with some enrichment in nucleoli. On CPT treatment, cleared from nucleoli into nucleoplasm. Sumolyated forms found in both nucleoplasm and nucleoli.

Target information above from: UniProt accessionP11387 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • DNA topoisomerase 1 antibody
  • DNA topoisomerase I antibody
  • NUP98 fusion gene antibody
  • TOP 1 antibody
  • TOP I antibody
  • TOP1 antibody
  • TOP1_HUMAN antibody
  • TOPI antibody
  • Topoisomerase (DNA) I antibody
  • Topoisomerase 1 antibody
  • Topoisomerase1 antibody
  • TopoisomeraseI antibody
  • Type I DNA topoisomerase antibody
see all

Anti-Topoisomerase I antibody images:

  Immunocytochemistry/ Immunofluorescence-Topoisomerase I antibody(ab28432)

Immunocytochemistry/ Immunofluorescence-Topoisomerase I antibody(ab28432)

ICC/IF image of ab28432 stained MCF-7 cells. The cells were 4% formaldehyde fixed (10 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab28432, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.
Text
Text

  Immunocytochemistry/ Immunofluorescence - Topoisomerase I antibody (ab28432)

Immunocytochemistry/ Immunofluorescence - Topoisomerase I antibody (ab28432)

ICC/IF image of ab28432 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab28432, 1µg/ml) overnight at +4°C. The secondary antibody (green) was DyLight® 488 goat anti-rabbit IgG - H&L, pre-adsorbed (ab96899) used at a 1/250 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-Topoisomerase I antibody (ab28432)

This product has been referenced in:

  • D'Onofrio Get al. Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells. Biochem Pharmacol 81:194-202 (2011). WB; Human.Read more (PubMed: 20875401) »
  • Pfister TDet al. Topoisomerase I levels in the NCI-60 cancer cell line panel determined by validated ELISA and microarray analysis and correlation with indenoisoquinoline sensitivity. Mol Cancer Ther 8:1878-84 (2009). ELISA; Human.Read more (PubMed: 19584232) »

See all 3 publications for this product

Publishing research using ab28432? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"